Deuruxolitinib

DRUG2 trials

Sponsors

Sun Pharmaceutical Industries, Inc., Sun Pharma Japan Limited

Conditions

Alopecia Areata

Phase 3

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

RecruitingNCT07133308

Sun Pharmaceutical Industries, Inc.Alopecia Areata

Start: 2025-08-05End: 2028-05-01Target: 355Updated: 2026-01-28

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia Areata

RecruitingNCT07617597

Sun Pharma Japan LimitedAlopecia Areata

Start: 2026-06-19End: 2028-09-01Target: 78Updated: 2026-08-18